• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下植入式心脏复律除颤器植入过程中除颤测试时因噪声感知不当导致休克疗法未实施:一例报告

Absence of shock therapy related to improper sensing of noise on the defibrillation test during subcutaneous implantable cardioverter-defibrillator implantation: a case report.

作者信息

Tamura Shota, Yoshiyama Tomotaka, Doi Atsushi, Yoshiyama Minoru

机构信息

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.

出版信息

Eur Heart J Case Rep. 2020 Dec 2;4(6):1-6. doi: 10.1093/ehjcr/ytaa469. eCollection 2020 Dec.

DOI:10.1093/ehjcr/ytaa469
PMID:33447710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7793213/
Abstract

BACKGROUND

Subcutaneous implantable cardioverter-defibrillator (S-ICD) represents an efficient alternative to transvenous ICD in patients who do not require pacing. The intraoperative defibrillation test (DFT) is recommended during S-ICD implantation to confirm appropriate sensing and successful 65-J termination of induced ventricular fibrillation (VF). However, few cases of oversensing of noise inhibiting therapies have been reported.

CASE SUMMARY

We report the case of a 50-year-old man who underwent S-ICD implantation for secondary prevention of sudden cardiac death. Immediately after S-ICD implantation, VF was induced using a 50-Hz burst; however, shock was not delivered owing to sustained noise on the electrogram in the primary vector. Therefore, an external rescue shock was needed at 150 J. We changed the sensing vector from primary to secondary and performed a second DFT. The S-ICD could deliver an appropriate shock and was able to successfully terminate VF without noise markers in the secondary vector. During the second DFT, one back-up pacing was delivered after the shock; the sensing vector then automatically switched from the secondary to the alternate vector. However, noise was observed in the alternate vector despite sinus rhythm restoration.

DISCUSSION

The present case demonstrated that noise was recorded in two different vectors during DFT, possibly supporting the hypothesis that the muscle spasm of the diaphragm induced by the 50-Hz burst causes oversensing of noise by the S-ICD.

摘要

背景

皮下植入式心律转复除颤器(S-ICD)是不需要起搏的患者经静脉植入式心律转复除颤器的有效替代方案。在植入S-ICD期间建议进行术中除颤测试(DFT),以确认适当的感知以及能否成功以65焦耳终止诱发的心室颤动(VF)。然而,很少有关于噪声抑制治疗感知过度的病例报道。

病例摘要

我们报告了一名50岁男性的病例,该患者因心脏性猝死的二级预防接受了S-ICD植入。在植入S-ICD后立即使用50赫兹猝发刺激诱发VF;然而,由于主向量心电图上持续出现噪声,未发放电击。因此,需要150焦耳的体外抢救电击。我们将感知向量从主向量改为次向量,并进行了第二次DFT。S-ICD能够发放适当的电击,并能够在次向量中成功终止VF且无噪声标记。在第二次DFT期间,电击后发放了一次备用起搏;然后感知向量自动从次向量切换到备用向量。然而,尽管恢复了窦性心律,但在备用向量中仍观察到噪声。

讨论

本病例表明,在DFT期间,在两个不同向量中记录到了噪声,这可能支持以下假设,即50赫兹猝发刺激诱发的膈肌肌肉痉挛导致S-ICD对噪声的感知过度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/9753ee6c2cb0/ytaa469f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/95d1a5aa071f/ytaa469f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/e59588a6b7f0/ytaa469f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/0354dd1993bb/ytaa469f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/9753ee6c2cb0/ytaa469f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/95d1a5aa071f/ytaa469f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/e59588a6b7f0/ytaa469f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/0354dd1993bb/ytaa469f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7260/7793213/9753ee6c2cb0/ytaa469f4.jpg

相似文献

1
Absence of shock therapy related to improper sensing of noise on the defibrillation test during subcutaneous implantable cardioverter-defibrillator implantation: a case report.皮下植入式心脏复律除颤器植入过程中除颤测试时因噪声感知不当导致休克疗法未实施:一例报告
Eur Heart J Case Rep. 2020 Dec 2;4(6):1-6. doi: 10.1093/ehjcr/ytaa469. eCollection 2020 Dec.
2
Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection.除颤测试是皮下植入式心律转复除颤器患者的强制性要求,以确认适当的心室颤动检测。
Heart Rhythm. 2018 May;15(5):642-650. doi: 10.1016/j.hrthm.2018.02.013.
3
Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.在 Brugada 综合征病例中,频繁治疗室颤风暴后对皮下植入式心律转复除颤器产生抗药性。
BMC Cardiovasc Disord. 2020 Mar 13;20(1):134. doi: 10.1186/s12872-020-01405-4.
4
Inappropriate subcutaneous implantable cardioverter defibrillator shock due to incomplete sealing of the seal plug: a case report.因密封插头密封不完全导致不适当的皮下植入式心律转复除颤器电击:一例报告
Eur Heart J Case Rep. 2022 Sep 3;6(9):ytac366. doi: 10.1093/ehjcr/ytac366. eCollection 2022 Sep.
5
Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?皮下植入式心脏复律除颤器系统的术中除颤测试——一个简单的问题?
J Am Heart Assoc. 2016 Mar 15;5(3):e003181. doi: 10.1161/JAHA.115.003181.
6
High defibrillation threshold with right-sided ICD implantation was resolved by a dual coil lead via persistent left superior vena cava.通过经持续左上腔静脉的双线圈导线解决了右侧植入式心律转复除颤器(ICD)植入时的高除颤阈值问题。
J Cardiol Cases. 2021 Nov 22;25(5):262-265. doi: 10.1016/j.jccase.2021.10.012. eCollection 2022 May.
7
Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death - Primary Japanese Experience.皮下植入式心律转复除颤器在高危心源性猝死患者中的安全性和有效性:日本初步经验。
Circ J. 2018 May 25;82(6):1546-1551. doi: 10.1253/circj.CJ-17-1001. Epub 2018 Apr 11.
8
[Implantable cardioverter-defibrillator oversensing due to electric shock].
Srp Arh Celok Lek. 2010 Mar-Apr;138(3-4):236-9. doi: 10.2298/sarh1004236j.
9
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.肥厚型心肌病患者皮下植入式心律转复除颤器:初步经验
J Am Heart Assoc. 2016 Feb 12;5(2):e002488. doi: 10.1161/JAHA.115.002488.
10
[Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].[术中双次除颤阈值能量的植入式心律转复除颤器(ICD)程控在长期随访中是否安全有效?一项前瞻性随机多中心研究的结果(低能量Endotak试验——LEET)]
Z Kardiol. 1999 Feb;88(2):103-12. doi: 10.1007/s003920050266.

本文引用的文献

1
Noise caused by involuntary muscle response may inhibit detection of ventricular fibrillation during defibrillation testing.除颤测试期间,非自主肌肉反应引起的噪音可能会抑制心室颤动的检测。
HeartRhythm Case Rep. 2019 Dec 11;6(3):126-130. doi: 10.1016/j.hrcr.2019.11.004. eCollection 2020 Mar.
2
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.皮下与经静脉植入式心脏除颤器治疗:病例对照研究的荟萃分析。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
3
Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection.
除颤测试是皮下植入式心律转复除颤器患者的强制性要求,以确认适当的心室颤动检测。
Heart Rhythm. 2018 May;15(5):642-650. doi: 10.1016/j.hrthm.2018.02.013.
4
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Circulation. 2018 Sep 25;138(13):e272-e391. doi: 10.1161/CIR.0000000000000549.
5
Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.皮下植入式心脏复律除颤器注册研究的植入和中期结果:EFFORTLESS 研究。
J Am Coll Cardiol. 2017 Aug 15;70(7):830-841. doi: 10.1016/j.jacc.2017.06.040.
6
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2015年心律学会(HRS)/欧洲心律协会(EHRA)/亚太心律学会(APHRS)/拉丁美洲心律学会(SOLAECE)关于植入式心脏复律除颤器最佳程控与测试的专家共识声明
Europace. 2016 Feb;18(2):159-83. doi: 10.1093/europace/euv411. Epub 2015 Nov 19.
7
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).2015年欧洲心脏病学会(ESC)室性心律失常患者管理和心脏性猝死预防指南:欧洲心脏病学会(ESC)室性心律失常患者管理和心脏性猝死预防特别工作组。认可机构:欧洲儿科和先天性心脏病协会(AEPC)。
Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29.
8
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).心脏转复除颤器植入术无需诱发心室颤动:一项单盲、非劣效性、随机对照试验(SIMPLE)。
Lancet. 2015 Feb 28;385(9970):785-91. doi: 10.1016/S0140-6736(14)61903-6. Epub 2015 Feb 23.
9
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.完全皮下植入式心脏除颤器的安全性和有效性。
Circulation. 2013 Aug 27;128(9):944-53. doi: 10.1161/CIRCULATIONAHA.113.003042.